PDGFRB and glioblastoma: As specific gene silencing of PDGF-Rα and PDGF-Rβ enhanced neurite-like process growth in U87 GBM cells and G179 GSCs, these data suggest that the observed impact of CP-673451 treatment on GBM cells should be, at least partly, due to specific PDGF-Rα/β inhibition.